FDA vaccine advisers votes to recommend booster doses in people 65 and older and those at high risk
From CNN's Maggie Fox
Vaccine advisers to the US Food and Drug Administration voted unanimously Friday to recommend emergency use authorization of a booster dose of Pfizer’s vaccine six months after full vaccination in people 65 and older and those at high risk of severe Covid-19.
Members of the FDA’s Vaccines and Related Biological Products Advisory Committee had rejected a broader application – to approve the use of booster doses of Pfizer’s vaccines in everyone 16 and older six months after they are fully vaccinated.
So the FDA offered a revised question to vote on.
Members of the committee expressed doubts about the safety of a booster dose in younger adults and teens, and complained about the lack of data about the safety and long term efficacy of a booster dose.
Remember: The meeting and vote is just the start of the process. It's the US Centers for Disease Control and Prevention who will decide whether or not they should be used.
https://www.cnn.com/world/live-news/coronavirus-vaccine-booster-news-09-17-21/index.html